TSXV - Delayed Quote CAD

Ocumetics Technology Corp. (OTC.V)

0.3850
+0.0050
+(1.32%)
At close: June 13 at 3:33:52 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.
NameTitlePayExercisedYear Born
Dr. Garth T. Webb Founder, Chairman & Chief Scientific Officer 108k -- --
Mr. Dean E. Burns President, CEO & Director 130.6k -- --
Mr. Roger M. Jewett C.A., CPA CFO & Director 146.65k -- 1965
Dr. R. Doyle Stulting Chief Medical Officer & Director 324.4k -- --

Ocumetics Technology Corp.

1250, 639-5th Avenue SW
Calgary, AB T2P 0M9
Canada
https://ocumetics.com
Sector: 
Healthcare

Description

Ocumetics Technology Corp. engages in research, development, production, and sale of vision enhancement products in Canada. The company develops expandable intraocular lenses to eliminate the need for corrective lenses primarily for people over 45 years of age. The company was formerly known as Quantum Blockchain Technologies Ltd. and changed changed its name to Ocumetics Technology Corp. in August 2021. Ocumetics Technology Corp. was founded in 2012 and is headquartered in Calgary, Canada.

Corporate Governance

Ocumetics Technology Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events